Anti-influenza virus pyrimidine derivatives

US12319692B2 · kind B2 · utility

Assignee

• GUANGDONG RAYNOVENT BIOTECH CO., LTD. · CN

Inventors

• Jian Xiong · Shanghai, CN
• Chaofeng Long · Tangxia, CN
• Jingjing Wang · Shanghai, CN
• Xiaoxin Chen · Cupertino, US
• Kevin X. Chen · Edison, US
• Cheng Xie · Shanghai, CN
• Peng Li · New York, US
• Xuanjia Peng · Shanghai, CN
• Jian Li · Shanghai, CN
• Shuhui CHEN · Shanghai, CN

Key dates

• Filing date: Jun 19, 2023
• Grant date: Jun 3, 2025
• Expiry date: Jun 19, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07B2200/07
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention discloses a class of anti-influenza virus compounds, and the use thereof in the preparation of a drug for treating diseases associated with influenza viruses. In particular, the present invention discloses a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.